The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

As with any type of tumor, brain tumors are an abnormal growth of cells, the number of which will determine, in part, the overall size of the tumor. In the case of benign brain tumors, these cells ...

Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm, ...

Lab tests have found that bioactive glasses doped with the gallium have a 99% success rate of eliminating cancerous cells and ...

The findings, published in Nature Immunology, indicate that tumors edit the activity of multiple genes to avoid immune ...

The adoption of QIAcuity digital PCR remains strong with more than 2,000 cumulative placements at the end of 2023 and citations in over 450 publications. Key customers include pharmaceutical and ...

Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy ...

Merck & Co. has won its first U.S. approval for use of its blockbuster cancer drug Keytruda in patients with malignant pleural mesothelioma, a rare cancer that grows in the membrane that lines the ...

Bad breath can cause discomfort for both the person and those around them, according to the Ukrainian therapist Mykhailo ...

Recent data shows that areas with high radon levels may increase the incidence of non-malignant tumors up to 26% and strokes ...

Researchers sought to assess the reporting of patient-reported outcomes in associated clinical trial publications.

In fact, survival rates in children with malignant tumors and blood cancers have risen dramatically over the past decades.